Expression of biologically active atrial natriuretic factor following intrahepatic injection of a replication-defective adenoviral vector in dogs

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 281-290

  Chetboul, Valerie ^a   Adam, Micheline ^a   Deprez, Isabelle ^a,b   Ambriovic, Andreja ^a   Rosenberg, Dan ^a   Crespeau, François ^a   Saana, Moez ^a   Pham, Isabelle ^b   Eloit, Marc ^a   Adnot, Serge ^b   Pouchelon, Jean Louis ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COMPLEMENTARY DNA; CYCLIC GMP; LUCIFERASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIURESIS; DOG; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HEART OUTPUT; LONG TERMINAL REPEAT; MALE; NATRIURESIS; NONHUMAN; REPORTER GENE; ROUS SARCOMA ONCOVIRUS; TIME; URINARY EXCRETION; WEIGHT GAIN;

ADENOVIRIDAE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CELL LINE; DEFECTIVE VIRUSES; DNA PRIMERS; DNA, COMPLEMENTARY; DOGS; DRUG ADMINISTRATION ROUTES; GENETIC VECTORS; HUMANS; LIVER; LUCIFERASES; MALE;

EID: 0033585464     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019066     Document Type: Article

References (32)

1. BIE, P., WANG, B.C., LEADLEY, R.J., and GOETZ, K.L. (1988). Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. Am. J. Physiol. 254(2 Pt. 2), R161-169.
2. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 612, 156-159.
3. CONDRA, C.L., LEIDY, E.A., BUNTING, P., COLTON, C.D., NUTT, R.F., ROSENBLATT, M., and JACOBS, J.W. (1988). Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage. J. Clin. Invest. 81(5), 1348-1354.
4. EDWARDS, B.S., ZIMMERMAN, R.S., SCHWAB, T.R., HEUBLEIN, D.M., and BURNETT, J.C. (1988). Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ. Res. 62, 191-195.
5. ELOIT, M., GILARDI-HEBESTREIT, P., TOMA, B., and PERRICAUDET, M. (1990). Contraction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 71, 2425-2431.
6. ELOIT, M., ADAM, M., GALLAIS, I., and FOURNIER, A. (1997). High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes. J. Virol. 71(7), 1-7.
7. GANAU, A., DEVEREUX, R.B., ATLAS, S.A., PECKER, M., ROMAN, M.J., VARGIU, P., CODY, R.J., and LARAGH, J.H. (1989). Plasma atrial natriuretic factor in essential hypertension: Relation to cardiac size, function and systemic hemodynamics. J. Am. Coll. Cardiol. 14(3), 715-724. [Discussion on pp. 725-727].
8. GARCIA, R., THIBAULT, G., GUTKOWSKA, J., HAMET, P., CANTIN, M., and GENEST, J. (1985). Effect of chronic infusion of synthetic atrial natriuretic factor (ANF 8-33) in conscious two-kidney, one-clip hypertensive rats. Proc. Soc. Exp. Biol. Med. 178(1), 155-159.
9. GERARD, R.D., and MEIDELL, R.S. (1993). Adenovirus-mediated gene transfer. Trends Cardiovasc. Med. 3, 171-177.
10. GRAHAM, F.L., SMILEY, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-67.
11. JOOSS, K., ERTL, H.C., and WILSON, J.M. (1998). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72, 2945-2954.
12. KASS-EISLER, A., FALCK-PETERSEN, E., ELFENBEIN, D.H., ALVIRA, M., BUTTRICK, P.M., and LEINWAND, L.A. (1994). The impact of developmental stage of administration and the immune system on adenovirus-mediated transfer. Gene Ther. 1, 395-402.
13. LAROCHELLE, P., CUSSON, J.R., GUTKOWSKA, J., SCHIFFRIN, E.L., HAMET, P., KUCHEL, O., GENEST, J., and CANTIN, M. (1987). Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. Br. Med. J. 294(6582), 1249-1252.
14. LEE, M.E., MILLER, W.L., EDWARDS, B.S., and BURNETT, J.C. (1989). Role of endogenous atrial natriuretic factor in acute congestive heart failure. J. Clin. Invest. 84(6), 1962-1966.
15. LIN, K.F., CHAO, J., and CHAO, L. (1995). Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 26(6 Pt. 1), 847-853.
16. LUSKY, M., CHRIST, M., RITTNER, K., DIETERLE, A., DREYER, D., MOUROT, B., SCHULTZ, H., STOECKEL, F., PAVIRANI, A., and MEHTALI, M. (1998). In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J. Virol. 72, 2022-2032.
17. MORISHITA, R., GIBBONS, G.H., PRATT, R.E., TOMITA, N., KANEDA, Y., OGIHARA, T., and DZAU, V.J. (1994). Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J. Clin. Invest. 94(2), 824-829.
18. NORTHRIDGE, D.B., ALABASTER, C.T., CONNELL, C.T., DARGIE, H.J., DILLY, S.G., FINOLAY, I.N., LEVER, A.F., and SAMUELS, G.M. (1989). Effects of UK 69 578: A novel atriopeptidase inhibitor. Lancet ii, 591-593.
19. OIKAWA, S., IMAI, M., INUZUKA, C., TAWARAGI, Y., NAKAZATO, H., and MATSUO, H. (1985). Structure of dog and rabbit precursors of atrial natriuretic polypeptides deduced from nucleotide sequence of cloned cDNA. Biochem. Biophys. Res. Commun. 132(3), 892-899.
20. OUALIKENE, W., GONIN, P., and ELOIT, M. (1995). Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat. J. Virol. 69, 6518-6524.
21. PHAM, I., HIRA, M., ADAM, M., ELOIT, M., and ADNOT, S. (1997). Adenovirus mediated atrial natriuretic peptide (ANP) gene transfer in rat pulmonary vascular smooth muscle cells. Am. J. Respir Crit. Care Med. 155(4), A462. [Abstract]
22. RAFFESTIN, B., LEVAME, M., EDDAHIBI, S., VIOSSAT, I., BRAQUET, P., CHABRIER, P.E., CANTIN, M., and ADNOT, S. (1992). Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension. Circ. Res. 70, 184-192.
23. RAINE, A.E., ERNE, P., BÜRGISSER, E., MÜLLER, F.B., BOLLI, P., BURKART, F., and BÜHLER, F.R. (1986). Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N. Engl. J. Med. 315(9), 533-537.
24. RICHARDS, A.M., TONOLO, G., TREE, M., ROBERTSON, J.I., MONTORSI, P., LECKIE, B.J., and POLONIA, J. (1988). Atrial natriuretic peptides and renin release. Am. J. Med. 84(3A), 112-118.
25. RICHARDS, A.M., TREE, M., TONOLO, G., MONTORSI, P., POLONIA, J., MORTON, J.J., FRASER, R., and FRAMTON, C. (1993). Atrial natriuretic factor and changes in the aldosterone response to angiotensin II in sodium depleted dog. Clin. Exp. Hypert. 15(2), 379-394.
26. SAITO, Y., NAKAO, K., NISHIMURA, K., SUGAWARA, A., OKUMURA, K., OBATA, K., SONODA, R., BAN, T., YASUE, H., and IMURA, H. (1987). Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 76(1), 115-124.
27. SAS Institute, Inc. (1996). SAS/STAT software: Changes and enhancements through release 6.11. SAS Institute (Cary, NC).
28. SCHWARTZ, J.-C., GROS, C., LECOMTE, J.-M., and BRALET, J. (1991). Protection of endogenous ANF against inactivation: Potential therapeutic applications of enkephalinase inhibitors. In Atrial Natiuretic Factor: Physiological and Clinical Aspects. Medicine-Sciences (Paris, France, Flammarion) pp. 21-34.
29. SHENK, T., and WILLIAMS, J. (1984). Genetic analysis of adenovirus. Curr. Top. Microbiol. Immunol. 111, 1-39.
30. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vector. Nature Med. 2(5), 545-550.
31. UEHARA, Y., KOGA, M., and TAKAHASHI, M. (1995). Determination of cardiac output by echocardiography. J. Vet. Sci. 57(3), 401-407.
32. VOLPE, M., CUOCOLO, A., VECCHIONE, F., MELE, A.F., CONDORELLI, M., and TRIMARCO, B. (1987). Vagal mediation of the effects of atrial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit. Circ. Res. 60(5), 747-755.